A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)
Clinical trial NCT07222189 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07222189
- Sponsor
- Sanofi
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-19
- Primary completion
- 2030-05-10
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.